Diabetes and metabolism Archives - Page 4 of 7

Clinical Articles

GLP-1 restrictions will make care trickier, but GPs supportive

Healthed survey finds that while many expect negative impact, they support changes...

Videos

Allurion Intragastric Balloon-based Program for weight loss

In this Product Explainer, Bariatrician Prof John Dixon explains how the Allurion intragastric balloon works as part of a non-surgical weight loss strategy.

Clinical Articles

Managing diabetic retinopathy

1 in 3 people with diabetic retinopathy are at high risk of vision loss, yet screening rates remain low…

Podcasts

Prevention and management of diabetic retinopathy – Lecture

Prof Richard O'Brien, explains that diabetic retinopathy is a common but often very manageable complication of diabetes, provided it is detected early.

Podcasts

Practical guide to tirzepatide – Lecture

In this Healthed lecture, A/Prof Samantha Hocking provides an update on what this new treatment is.

Videos

Finerenone for chronic kidney disease in type 2 diabetes

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

Clinical Articles

Is diabetes remission really as hard to achieve as a new study suggests?

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Clinical Articles

Preventing DKA in kids – tips to make a timely type 1 diabetes diagnosis

Cases of diabetic ketoacidosis (DKA) in children are on the rise in Australia, sometimes with tragic consequences, says paediatric endocrinologist A/Prof Gary Leong—and empirical evidence supports this observation.

Podcasts

Weight loss for better type 2 diabetes outcomes – Your questions answered

The questions answered in this podcast are listed. They were compiled by GPs and health professionals around Australia regarding weight loss for better type 2 diabetes outcomes.

Clinical Articles

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Clinical Articles

Ozempic drought continues

Worldwide shortages cause to TGA put the brakes on prescribing

Expert/s: Healthed

Clinical Articles

Body mass index: why practitioners are relying on it less when looking at a patient’s health

ody mass index has long been used by doctors as the standard method for measuring health – and often still is.

Expert/s: Healthed

Diabetes and metabolism

GLP-1 restrictions will make care trickier, but GPs supportive

Healthed survey finds that while many expect negative impact, they support changes...

Allurion Intragastric Balloon-based Program for weight loss

In this Product Explainer, Bariatrician Prof John Dixon explains how the Allurion intragastric balloon works as part of a non-surgical weight loss strategy.

Managing diabetic retinopathy

1 in 3 people with diabetic retinopathy are at high risk of vision loss, yet screening rates remain low…

Prevention and management of diabetic retinopathy – Lecture

Prof Richard O'Brien, explains that diabetic retinopathy is a common but often very manageable complication of diabetes, provided it is detected early.

Practical guide to tirzepatide – Lecture

In this Healthed lecture, A/Prof Samantha Hocking provides an update on what this new treatment is.

Finerenone for chronic kidney disease in type 2 diabetes

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

Is diabetes remission really as hard to achieve as a new study suggests?

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Preventing DKA in kids – tips to make a timely type 1 diabetes diagnosis

Cases of diabetic ketoacidosis (DKA) in children are on the rise in Australia, sometimes with tragic consequences, says paediatric endocrinologist A/Prof Gary Leong—and empirical evidence supports this observation.

Weight loss for better type 2 diabetes outcomes – Your questions answered

The questions answered in this podcast are listed. They were compiled by GPs and health professionals around Australia regarding weight loss for better type 2 diabetes outcomes.

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Ozempic drought continues

Worldwide shortages cause to TGA put the brakes on prescribing

Body mass index: why practitioners are relying on it less when looking at a patient’s health

ody mass index has long been used by doctors as the standard method for measuring health – and often still is.

Get the app

Site

Company

Connect

Legal

Healthed

Upcoming Healthed Webcast

Tune in for "Gallbladder – When surgery is or is not needed" lecture

Tuesday 26th May, 7pm - 9pm AEST

Speaker

Dr David Yeo

Specialist Upper GI, Hepatobiliary and Bariatric Surgeon; Chris O’Brien Lifehouse, RPA and St George Hospitals

In this talk, surgeon, Dr David Yeo will answer these and many other real-world questions related to this common condition and provide an update on the latest recommendations for the assessment, investigation and management of gallbladder disease.

Diabetes and metabolism

Healthed survey finds that while many expect negative impact, they support changes...

In this Product Explainer, Bariatrician Prof John Dixon explains how the Allurion intragastric balloon works as part of a non-surgical weight loss strategy.

1 in 3 people with diabetic retinopathy are at high risk of vision loss, yet screening rates remain low…

Prof Richard O'Brien, explains that diabetic retinopathy is a common but often very manageable complication of diabetes, provided it is detected early.

In this Healthed lecture, A/Prof Samantha Hocking provides an update on what this new treatment is.

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Cases of diabetic ketoacidosis (DKA) in children are on the rise in Australia, sometimes with tragic consequences, says paediatric endocrinologist A/Prof Gary Leong—and empirical evidence supports this observation.

The questions answered in this podcast are listed. They were compiled by GPs and health professionals around Australia regarding weight loss for better type 2 diabetes outcomes.

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Worldwide shortages cause to TGA put the brakes on prescribing

ody mass index has long been used by doctors as the standard method for measuring health – and often still is.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

Upcoming Healthed Webcast

Tune in for "Gallbladder – When surgery is or is not needed" lecture

Tuesday 26th May, 7pm - 9pm AEST

Speaker

Dr David Yeo

Specialist Upper GI, Hepatobiliary and Bariatric Surgeon; Chris O’Brien Lifehouse, RPA and St George Hospitals

In this talk, surgeon, Dr David Yeo will answer these and many other real-world questions related to this common condition and provide an update on the latest recommendations for the assessment, investigation and management of gallbladder disease.